- Home
- CNC vs CHWY Comparison
CNC vs CHWY Comparison
Compare CNC & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNC
- CHWY
- Stock Information
- Founded
- CNC 1984
- CHWY 2010
- Country
- CNC United States
- CHWY United States
- Employees
- CNC N/A
- CHWY N/A
- Industry
- CNC Medical Specialities
- CHWY Catalog/Specialty Distribution
- Sector
- CNC Health Care
- CHWY Consumer Discretionary
- Exchange
- CNC Nasdaq
- CHWY Nasdaq
- Market Cap
- CNC 14.3B
- CHWY 16.5B
- IPO Year
- CNC 2001
- CHWY 2019
- Fundamental
- Price
- CNC $35.91
- CHWY $33.16
- Analyst Decision
- CNC Hold
- CHWY Strong Buy
- Analyst Count
- CNC 16
- CHWY 25
- Target Price
- CNC $37.07
- CHWY $45.17
- AVG Volume (30 Days)
- CNC 11.1M
- CHWY 5.9M
- Earning Date
- CNC 10-29-2025
- CHWY 12-03-2025
- Dividend Yield
- CNC N/A
- CHWY N/A
- EPS Growth
- CNC N/A
- CHWY N/A
- EPS
- CNC N/A
- CHWY 0.35
- Revenue
- CNC $181,675,000,000.00
- CHWY $12,345,235,000.00
- Revenue This Year
- CNC $30.96
- CHWY $8.47
- Revenue Next Year
- CNC N/A
- CHWY $8.12
- P/E Ratio
- CNC N/A
- CHWY $96.14
- Revenue Growth
- CNC 24.14
- CHWY 9.17
- 52 Week Low
- CNC $25.08
- CHWY $26.28
- 52 Week High
- CNC $66.81
- CHWY $48.62
- Technical
- Relative Strength Index (RSI)
- CNC 53.93
- CHWY 25.74
- Support Level
- CNC $32.87
- CHWY $36.64
- Resistance Level
- CNC $37.57
- CHWY $38.95
- Average True Range (ATR)
- CNC 1.21
- CHWY 0.95
- MACD
- CNC -0.24
- CHWY -0.46
- Stochastic Oscillator
- CNC 64.61
- CHWY 0.46
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
About CHWY Chewy Inc.
Chewy is the largest e-commerce petcare retailer in the US, generating $11.9 billion in fiscal 2024 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods like crates, leashes, and bowls.